NCT05343884

Brief Summary

This will be a prospective randomized clinical trial comprising of n=300 diabetic patients, randomized to either dynamic (n=150) or conventional MPI (n=150) strategy. Healthcare resources utilization of each patient will be tracked. Patients will be followed up for short term outcomes and for long term outcomes.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P50-P75 for not_applicable coronary-artery-disease

Timeline
Completed

Started Mar 2022

Typical duration for not_applicable coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 15, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

March 15, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 25, 2022

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

April 25, 2022

Status Verified

April 1, 2022

Enrollment Period

3 years

First QC Date

March 15, 2022

Last Update Submit

April 19, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Diagnostic Failure

    The primary end-point is diagnostic failure, defined as unnecessary coronary angiography (absence of ≥50% stenosis in ≥1 coronary arteries) or any additional coronary testing (example, computed tomography of coronary arteries).

    Up to 12 months

Secondary Outcomes (1)

  • Secondary end-points

    Up to 12 months

Study Arms (2)

Dynamic myocardial perfusion imaging

OTHER

Dynamic myocardial perfusion imaging is performed to obtain additional measurements of coronary blood flow, compared to conventional imaging.

Radiation: Myocardial perfusion imaging

Conventional myocardial perfusion imaging

OTHER

Conventional myocardial perfusion imaging which is based on standard routine clinical myocardial perfusion imaging.

Radiation: Myocardial perfusion imaging

Interventions

Myocardial perfusion imaging

Conventional myocardial perfusion imagingDynamic myocardial perfusion imaging

Eligibility Criteria

Age21 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diabetic patients without known coronary artery disease referred for MPI

You may not qualify if:

  • History of percutaneous coronary intervention, coronary artery bypass graft surgery
  • Asthma
  • Chronic obstructive pulmonary disease (COPD)
  • Presence of cardiac devices such as pacemakers and implantable cardiac defibrillators

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Heart Centre Singapore

Singapore, 169609, Singapore

RECRUITING

MeSH Terms

Conditions

Coronary Artery DiseaseDiabetes Mellitus

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 15, 2022

First Posted

April 25, 2022

Study Start

March 15, 2022

Primary Completion

March 1, 2025

Study Completion

March 1, 2026

Last Updated

April 25, 2022

Record last verified: 2022-04

Locations